Medicinal cannabis ‘does not help depression and anxiety’
New research review suggests use of the drug can worsen psychotic symptoms
Using medicinal cannabis to treat people with mental health issues cannot be justified because there is little evidence that it works or is safe, according to a major new study.
The authors of the report, published in Lancet Psychiatry, analysed the results of a total of 83 trials dating back 40 years into the effects of medicinal cannabinoids on patients with conditions including depression, anxiety, attention-deficit hyperactivity disorder (ADHD), Tourette syndrome, post-traumatic stress disorder (PTSD) and psychosis.
The team of researchers, from Australia, concluded that evidence of a positive effect was rare. And THC, one of the derivatives of cannabis, was found to made people with psychosis worse, The Guardian reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The study authors say “a large body of research” suggests that cannabis use “can increase the occurrence of depression, anxiety, and psychotic symptom”.
“Further high-quality studies directly examining the effect of cannabinoids on treating mental disorders are needed,” they add.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Get your first six issues for £6–––––––––––––––––––––––––––––––
As Time magazine points out, the news comes as marijuana is “more mainstream than it’s ever been” with a growing number of US states “legalising it medicinally and recreationally”, millions of people “vaping products that contain the compound THC”, and non-psychoactive CBD “in everything from beauty products to seltzer water”.
In an article in Lancet Psychiatry commenting on the findings, psychiatry professor Dr Deepak Cyril D’Souza of Yale University School of Medicine argues that “in light of the paucity of evidence, the absence of good quality evidence for efficacy, and the known risk of cannabinoids, their use as treatments for psychiatric disorders cannot be justified at present”.
Earlier this year, new research connected marijuana use among teenagers to depression and suicide in early adulthood. Researchers found that “the odds of attempting suicide were almost 3.5 times worse among those who used cannabis before the age of 18 than those who did not,” according to The Guardian.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
How helpful are mental health apps?
Under the radar Market is booming, offering accessibility and affordability, but many apps are unregulated and share sensitive user data
By Harriet Marsden, The Week UK Published
-
How the transmission of Alzheimer's might be possible
The Explainer New research links dementia cases to injections of human growth hormone from deceased donors' brains
By Chas Newkey-Burden, The Week UK Published
-
Car fatality rates are driving up
The Explainer The dang Covid pandemic made us worse drivers
By Devika Rao, The Week US Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Workplace wellness programmes: a waste of time and money?
Talking Point Global corporate industry is booming but positive impact on staff well-being is debatable
By Harriet Marsden, The Week UK Published